Citation: A. Dirocco et al., SERTRALINE INDUCED PARKINSONIM - A CASE-REPORT AND AN IN-VIVO STUDY OF THE EFFECT OF SERTRALINE ON DOPAMINE METABOLISM, Journal of neural transmission, 105(2-3), 1998, pp. 247-251
Citation: Mm. Hoehn et Md. Yahr, PARKINSONISM - ONSET, PROGRESSION, AND MORTALITY (REPRINTED FROM NEUROLOGY, VOL 17, PG 427-442, 1967), Neurology, 50(2), 1998, pp. 1-16
Citation: T. Brannan et al., EFFECTS OF REPEATED ADMINISTRATION OF L-DOPA AND APOMORPHINE ON CIRCLING BEHAVIOR AND STRIATAL DOPAMINE FORMATION, Brain research, 784(1-2), 1998, pp. 148-153
Citation: T. Brannan et al., PERIPHERAL AND CENTRAL INHIBITORS OF CATECHOL-O-METHYL TRANSFERASE - EFFECTS ON LIVER AND BRAIN COMT ACTIVITY AND L-DOPA METABOLISM, Journal of neural transmission, 104(1), 1997, pp. 77-87
Citation: T. Brannan et al., AN IN-VIVO COMPARISON OF THE CAPACITY OF STRIATAL VERSUS EXTRASTRIATAL BRAIN-REGIONS TO FORM DOPAMINE FROM EXOGENOUSLY ADMINISTERED L-DOPA, Journal of neural transmission, 103(11), 1996, pp. 1287-1294
Citation: M. Tagliati et al., THE PATTERN ELECTRORETINOGRAM IN PARKINSONS-DISEASE REVEALS LACK OF RETINAL SPATIAL TUNING, Electroencephalography and clinical neurophysiology. Evoked potentials, 100(1), 1996, pp. 1-11
Citation: T. Brannan et al., ELEVATED STRIATAL DOPAMINE LEVELS FOLLOWING ADMINISTRATION OF D-DOPA AND ITS ALPHA-KETO ACID METABOLITE DHPPA - BEHAVIORAL AND PHYSIOLOGICAL-STUDIES IN-VIVO IN THE RAT, Brain research, 718(1-2), 1996, pp. 165-168
Authors:
BODISWOLLNER I
BOROD JC
CICERO B
HAYWOOD CS
RASKIN S
MYLIN L
SLIWINSKI M
FALK A
YAHR MD
Citation: I. Bodiswollner et al., MODALITY DEPENDENT CHANGES IN EVENT-RELATED POTENTIALS CORRELATE WITHSPECIFIC COGNITIVE FUNCTIONS IN NONDEMENTED PATIENTS WITH PARKINSONS-DISEASE, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 197-209
Authors:
MERCHANT CA
COHEN G
MYTILINEOU C
DIROCCO A
MOROS D
MOLINARI S
YAHR MD
Citation: Ca. Merchant et al., HUMAN TRANSPLACENTAL TRANSFER OF CARBIDOPA-LEVODOPA, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 239-242
Citation: Sp. Molinari et al., THE USE OF FAMOTIDINE IN THE TREATMENT OF PARKINSONS-DISEASE - A PILOT-STUDY, Journal of neural transmission. Parkinson's disease and dementia section, 9(2-3), 1995, pp. 243-247
Citation: T. Brannan et Md. Yahr, COMPARATIVE-STUDY OF SELEGILINE PLUS L-DOPA-CARBIDOPA VERSUS L-DOPA-CARBIDOPA ALONE IN THE TREATMENT OF PARKINSONS-DISEASE, Annals of neurology, 37(1), 1995, pp. 95-98
Authors:
BRANNAN T
PRIKHOJAN A
MARTINEZTICA J
YAHR MD
Citation: T. Brannan et al., IN-VIVO COMPARISON OF THE EFFECTS OF INHIBITION OF MAO-A VERSUS MAO-BON STRIATAL L-DOPA AND DOPAMINE METABOLISM, Journal of neural transmission, 10(2-3), 1995, pp. 79-89
Authors:
MYTILINEOU C
WERNER P
MOLINARI S
DIROCCO A
COHEN G
YAHR MD
Citation: C. Mytilineou et al., IMPAIRED OXIDATIVE DECARBOXYLATION OF PYRUVATE IN FIBROBLASTS FROM PATIENTS WITH PARKINSONS-DISEASE, Journal of neural transmission. Parkinson's disease and dementia section, 8(3), 1994, pp. 223-228
Citation: T. Brannan et al., EFFECT OF A SELECTIVE MAO-A INHIBITOR (RO-41-1049) ON STRIATAL L-DOPAAND DOPAMINE METABOLISM - AN IN-VIVO STUDY, Journal of neural transmission. Parkinson's disease and dementia section, 8(1-2), 1994, pp. 99-105
Authors:
OLANOW CW
FAHN S
MUENTER M
KLAWANS H
HURTIG H
STERN M
SHOULSON I
KURLAN R
GRIMES JD
JANKOVIC J
HOEHN M
MARKHAM CH
DUVOISIN R
REINMUTH O
LEONARD HA
AHLSKOG E
FELDMAN R
HERSHEY L
YAHR MD
Citation: Cw. Olanow et al., A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE, Movement disorders, 9(1), 1994, pp. 40-47
Citation: T. Brannan et al., EFFECT OF A SELECTIVE MAO-INHIBITOR (RO-41-1049) ON STRIATAL L-DOPA AND DOPAMINE METABOLISM - AN IN-VIVO STUDY, Neurology, 44(4), 1994, pp. 10000155-10000155
Citation: P. Werner et al., IMPAIRED OXIDATION OF PYRUVATE IN HUMAN EMBRYONIC FIBROBLASTS AFTER EXPOSURE TO L-DOPA, European journal of pharmacology, 263(1-2), 1994, pp. 157-162
Authors:
BRANNAN T
MARTINEZTICA J
DIROCCO A
YAHR MD
Citation: T. Brannan et al., LOW AND HIGH-DOSE BROMOCRIPTINE HAVE DIFFERENT EFFECTS ON STRIATAL DOPAMINE RELEASE - AN IN-VIVO STUDY, Journal of neural transmission. Parkinson's disease and dementia section, 6(2), 1993, pp. 81-87
Citation: T. Brannan et al., EFFECT OF REPEATED ELECTROCONVULSIVE SHOCK ON STRIATAL L-DOPA AND DOPAMINE METABOLISM - AN IN-VIVO STUDY, Journal of neural transmission. Parkinson's disease and dementia section, 6(1), 1993, pp. 35-44